NDC 55154-3942-05 - Solu-Cortef
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55154-3942
- Requested NDC
- 55154-3942-05
- Package NDCs from labels
- 55154-3942-5, 55154-3942-05
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2025-08-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Solu-Cortef - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2025-08-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55154-3942-5 | Solu-Cortef | 5 in 1 BAG | INJECTION, POWDER, FOR SOLUTION | 5 | 16 | |
| 55154-3942-5 | Solu-Cortef | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, FOR SOLUTION | 2 | 16 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55154-3942 | SOLU-CORTEF (HYDROCORTISONE SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION [CARDINAL HEALTH 107, LLC] | 15 | Current NDC, Legacy NDC, 2 package rows | 20250112_f5bb0854-a477-4e59-914b-eeeaef92a596.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55154-3942-5 | EA - Each | 55154-3942 | 8341a761-a60d-4db8-85cc-4e7a7c953056 | 1 | 2019-05-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| hydrocortisone sodium succinate | ACTIVE INGREDIENT | 50LQB69S1Z | SOLU-CORTEF (HYDROCORTISONE SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION [CARDINAL HEALTH] | 6 | |
| hydrocortisone | ACTIVE MOIETY | WI4X0X7BPJ | SOLU-CORTEF (HYDROCORTISONE SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION [CARDINAL HEALTH] | 6 | |
| benzyl alcohol | INACTIVE INGREDIENT | LKG8494WBH | SOLU-CORTEF (HYDROCORTISONE SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION [CARDINAL HEALTH] | 6 | |
| sodium phosphate, dibasic | INACTIVE INGREDIENT | GR686LBA74 | SOLU-CORTEF (HYDROCORTISONE SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION [CARDINAL HEALTH] | 6 | |
| SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INACTIVE INGREDIENT | KH7I04HPUU | SOLU-CORTEF (HYDROCORTISONE SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION [CARDINAL HEALTH] | 6 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Solu-Cortef | HYDROCORTISONE SODIUM SUCCINATE | Pharmacia & Upjohn Company LLC | 65eefd58-b166-4d71-ade6-45c8fdf86922 | 2026-08-27 | Warnings, Adverse reactions | NDA009866 0009-0011 105398 1738592 1738589 1738586 1738596 238755 1738594 1738590 4e9814fe-3089-4980-a207-bf0aa95d4c36 65eefd58-b166-4d71-ade6-45c8fdf86922 50LQB69S1Z |
| Para-Chord | HOMEOPATHIC LIQUID | Energetix Corporation | 9f8f646e-634a-47ff-b208-b2249d685e55 | 2026-08-11 | Warnings | GR686LBA74 |
| Hydrocortisone sodium succinate | HYDROCORTISONE SODIUM SUCCINATE | Apotex Corp. | bfe185a6-b657-2fbb-4ac2-e085373f15f3 | 2026-07-28 | Warnings, Adverse reactions | 238755 50LQB69S1Z |
| Hydrocortisone sodium succinate | HYDROCORTISONE SODIUM SUCCINATE | Zydus Lifesciences Limited | d533ebee-9f1c-42d7-9808-ae5d5e55741b | 2026-05-08 | 238755 50LQB69S1Z | |
| Hydrocortisone sodium succinate | HYDROCORTISONE SODIUM SUCCINATE | Zydus Pharmaceuticals USA Inc. | 37534164-9de5-4bb3-9f87-341dfcf90883 | 2026-05-08 | Warnings, Adverse reactions | 238755 50LQB69S1Z |
| CVS Pharmacy | SALINE LAXATIVE | CVS Pharmacy | edd58c52-18de-4ec4-aec3-44f3e17607a7 | 2026-02-17 | Warnings | GR686LBA74 |
| Equate Ready-to-Use Enema Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | WalMart | 04c7440e-5b25-4b63-9604-321298d51021 | 2026-01-29 | Warnings | GR686LBA74 |
| Quality Choice Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Chain Drug Marketing Association | 1cac3b6b-155b-47bb-bb79-17c55d345736 | 2026-01-28 | Warnings | GR686LBA74 |
| Sunmark Saline Single Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Strategic Sourcing Services LLC | 06720229-7d58-499e-b7de-cb4bda5ae416 | 2026-01-08 | Warnings | GR686LBA74 |
| HealthMart Saline Single Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Strategic Sourcing Services LLC | 689228de-1f3e-4205-853d-6004d6248857 | 2026-01-08 | Warnings | GR686LBA74 |
| Uro-MP | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE | Method Pharmaceuticals, LLC | 1e1b0dee-1a3b-4846-a212-c9febb3fc17d | 2025-10-29 | Warnings, Adverse reactions | KH7I04HPUU |
| Leader Ready to Use Saline Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Cardinal Health | 1b4f9c28-0547-4922-aa15-990c6fd9dc9f | 2025-09-29 | Warnings | GR686LBA74 |
| Saline Laxative | SALINE LAXATIVE | Major Pharmaceuticals | b3758ffe-1bac-4df6-9714-5e33e9d28d90 | 2025-09-16 | Warnings | GR686LBA74 |
| Solu-Cortef | HYDROCORTISONE SODIUM SUCCINATE | Cardinal Health 107, LLC | f5bb0854-a477-4e59-914b-eeeaef92a596 | 2025-08-21 | Warnings, Adverse reactions | NDA009866 55154-3942-5 55154-3942 55154394205 105398 238755 bc348e8f-69c8-4cf4-a685-324ee3ebde87 f5bb0854-a477-4e59-914b-eeeaef92a596 50LQB69S1Z |
| Solu-Cortef | HYDROCORTISONE SODIUM SUCCINATE | ProPharma Distribution | 386942d3-c75f-25f1-e063-6394a90a5af2 | 2025-07-18 | Warnings, Adverse reactions | NDA009866 105398 238755 50LQB69S1Z |
| Rexall Ready to use 4pk LAXATIVE | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Dolgencorp, LLC | 78509915-0ef1-4238-99a5-78a49a68f98f | 2025-07-07 | Warnings | GR686LBA74 |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | 17dec820-1b57-4ac9-82a8-419cab664a2f | 2025-06-27 | Warnings, Adverse reactions | GR686LBA74 |
| Saline Laxative | SODIUM PHOSPHATE | Walgreen Company | fb260df0-7bda-4299-84a5-44c8f9447798 | 2025-06-18 | Warnings | GR686LBA74 |
| PRISMASOL BGK2/0 | MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE | Vantive US Healthcare LLC | 7f675fee-8940-4ece-bb0c-75ac79d8708c | 2025-05-31 | Warnings, Adverse reactions | GR686LBA74 |
| Saline Enema | SODIUM PHOSPHATE MONOBASIC, SODIUM PHOSPHATE DIBASIC | Dynarex Corporation | 7c7b68af-4ef2-4f84-9279-9f7a91c8d9c5 | 2025-05-14 | Warnings | GR686LBA74 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.